Fundz

Kanvas Biosciences reported raising $11.8 Million in an initial SEC Form D filing, from an offering of $12 Million

PRIVATEJun 13, 2023$11.8M of $12M raised

Amount Raised

$11.8 Million

$11.8 Million sold, per SEC Form D (first sale Jun 1, 2023)

Round Type

Venture

Monmouth JunctionBiotechnologyHealthcare

Quick answer

Kanvas Biosciences raised $11.8 Million in a funding round, dated June 1, 2023. Kanvas Biosciences is based in Monmouth Junction, New Jersey, United States.

How much did Kanvas Biosciences raise?
Kanvas Biosciences raised $11.8 Million in a funding round on June 1, 2023.
What does Kanvas Biosciences do?
Kanvas Biosciences is building the world's first microbiome drug screening and drug discovery platform to accelerate live biotherapeutic product (LBP) development.
Where is Kanvas Biosciences based and how big is it?
Kanvas Biosciences is based in Monmouth Junction, New Jersey, United States. Fundz records about 42 employees.
Who are the decision-makers at Kanvas Biosciences?
Fundz holds 1 contact at Kanvas Biosciences. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Biotechnology around the same time

Companies in the same sectors as Kanvas Biosciences that raised within 45 days of this round, from Fundz verified event records.

  • Endolytix Technology raised $4.3M (Seed) on July 14, 2023.
  • INTRINSIC THERAPEUTICS raised $5.5M on July 14, 2023.
  • CurvaFix raised $39M (Series C) on July 14, 2023.
  • Petros Pharmaceuticals, Inc. raised an undisclosed amount (Funding Round) on July 13, 2023.
  • Petros Pharmaceuticals, Inc. raised $30M on July 13, 2023.
  • EIP Pharma, Inc. raised $810K (Seed) on July 10, 2023.

Who to call at Kanvas Biosciences, and when

A new round usually means Kanvas Biosciences is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Kanvas Biosciences raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Kanvas Biosciences, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Kanvas Biosciences. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Kanvas Biosciences

Location

1 DEER PARK DRIVE

Monmouth Junction, New Jersey, United States

About

Kanvas Biosciences is building the world's first microbiome drug screening and drug discovery platform to accelerate live biotherapeutic product (LBP) development. Leveraging its unparalleled ability to spatially map the microbiome and profile host-gene expression at single-cell resolution, the company is constructing the most comprehensive and robust microbiome data resource for future drug development. Kanvas Biosciences' technology was initially developed at Cornell University and exclusively licensed. The company's notable investors include DCVC, Lions Capital LLC, Cooke LLC, Uncommon Denominator, and Triple Impact Capital.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Kanvas Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Kanvas Biosciences's next move

See what Strategic adds

Kanvas Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.